1. Home
  2. TLIS

TLIS

Talis Biomedical Corporation

Logo Talis Biomedical Corporation

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-22-2024 11:33am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.

Founded: 2010 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 15.4M IPO Year: 2021
Target Price: $5.00 AVG Volume (30 days): 9.1K
Analyst Decision: Strong Sell Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -34.12 EPS Growth: N/A
52 Week Low/High: $4.35 - $9.32 Next Earning Date: 05-09-2024
Revenue: $2,134,000 Revenue Growth: -55.65%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: